COVID-19 Program Ends Today
Today, Tuesday, September 12, 2023, marks the end of PDPH’s COVID-19 program and the beginning of commercialization.
Bivalent COVID-19 vaccines are no longer be authorized for use. Any remaining products in your inventory must be immediately discarded.
Use of unauthorized product to vaccinate patients is not allowed. Instead, providers may privately purchase new 2023-2024 COVID-19 products or enroll in the Bridge Access Program to receive vaccine for eligible patients. Ordering for VFC/Bridge Access enrolled providers will open later this week after today’s ACIP meeting.
We want thank you all for your participation in this program helping to vaccinate Philadelphia residents against the COVID-19 virus. We hope that we can continue to work together to protect Philadelphians from vaccine preventable diseases.
Starting today, you can privately purchase new 2023-2024 COVID-19 products to vaccinate patients with private insurance and enroll in the Bridge Access Program to receive vaccine for eligible patients.
Bridge Access Program
Eligible providers interested in continuing to receive federally funded COVID-19 vaccine are encouraged to enroll in the Bridge Access Program. This program ensures the equitable distribution of COVID-19 vaccine to underinsured and uninsured patients 19 years and older.
Submit a pre-enrollment form today to begin the enrollment process and be among the first providers to offer 2023 – 2024 authorized COVID-19 vaccine to Philadelphia residents.